Medicenna TherapeuticsMDNAF
13F holders, Q2 2024 (June 30)1holders
$1.45avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Medicenna Therapeutics Corp. (MDNAF) in their 13F filings. The largest holder was ORG Partners LLC ($145K).
- Company
- Medicenna Therapeutics Corp.
- CUSIP
- 58490H107
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $145K |
| Exits | 0 | $0 |
Ownership 1 holders
| ORG Partners LLC | 0.02% | New | 100,000 | $145K |
"% of holder's portfolio" is MDNAF's weight in each manager's 13F, not the share of Medicenna Therapeutics Corp. the manager owns.